More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...
HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as ...
Human immunodeficiency virus (HIV) is a viral infection that attacks our immune systems. Infection enters the body by contact ...
Human immunodeficiency viruses (HIV) are insidious. They can evade the immune defense and antiviral drugs by becoming "latent ...
The 21-valent pneumococcal conjugate vaccine V116 is well tolerated in adults living with HIV and induces immunity to all 21 ...
Maldives is the first nation validated for eliminating mother-to-child transmission of HIV, hepatitis B & syphilis, ...
Sickle cell disease is a genetic disorder causing widespread suffering, particularly in marginalised communities, where ...
Nobel laureate Shimon Sakaguchi reflects on the role of regulatory T cells in peripheral immune tolerance and how the cells ...
The Food and Drug Administration (FDA) has approved Libtayo (cemiplimab-rwlc) for the adjuvant, or postsurgical, treatment of ...
ZME Science on MSN
$40 Per Year: We Finally Have a Good Shot to Defeat HIV Globally
The world just took its biggest swing yet at ending the HIV epidemic. It’s not a cure, but it’s the next best thing: a shot.
It's very unlikely to get HIV from kissing. Here's how HIV can be transmitted and tips to prevent the spread.
In 2006 immunologist and 2025 Nobel prize winner Shimon Sakaguchi co-wrote an article in Scientific American that now feels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results